An efficient organocatalytic enantioselective synthesis of chiral 1,4-benzodioxepines is described. By proper incorporation of an intramolecular oxetane desymmetrization process, a range of benzylic alcohols bearing an internal oxetane reacted in the presence of a suitable chiral phosphoric acid catalyst to form chiral 1,4-benzodioxepines with high enantioselectivity. This process provides a new catalytic asymmetric example of direct synthesis of seven-membered heterocycles with good stereocontrol.
The transition‐metal‐catalyzed carbonylation reaction is a useful approach for ketone synthesis. However, it is often problematic to use exogenous carbonyl reagents, such as gaseous carbon monoxide. In this manuscript, we report a novel palladium‐catalyzed coupling reaction of gem‐difluoroalkenes and aryl boronic acids that yields bioactive indane‐type ketones with an all‐carbon α‐quaternary center. Characterization and stoichiometric reactions of the key intermediates RCF2PdII support a water‐induced defluorination and cross‐coupling cascade mechanism. The vinyl difluoromethylene motif serves as an in situ carbonyl precursor which is unprecedented in transition‐metal‐catalyzed coupling reactions. It is expected to raise broad research interest from the perspectives of ketone synthesis, fluoroalkene functionalization, and rational design of new synthetic protocols based on the unique reactivity of difluoroalkyl palladium(II) species.
A sulfur-directed palladium-catalyzed C(sp3)–H α-arylation of 3-pyrrolines with arylboronic acids has been disclosed, providing a range of 2-aryl-3-pyrolines, which could be readily converted to various polysubstituted pyrrolidines.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.